|
시장보고서
상품코드
2125249
눈 건강 보조제 : 시장 인사이트, 경쟁 구도 및 시장 예측(2034년)Eye Health Supplements - Market Insights, Competitive Landscape, and Market Forecast - 2034 |
||||||
DelveInsight
개요 :
- 눈 건강 보충제 시장은 2025년에 27억 5,000만 달러로 추정되며, 2034년까지 54억 달러에 달할 것으로 전망됩니다. 이러한 성장의 배경에는 노화에 따른 전 세계 안과 질환 유병률 증가, 화면 사용으로 인한 디지털 눈의 피로 증가, 그리고 예방적이고 영양 중심의 눈 관리에 대한 소비자의 선호도 상승이 있습니다.
- 전 세계 눈 건강 보충제 시장은 2026-2034년까지의 예측 기간 중 연평균 성장률(CAGR) 7.8%로 성장하고 있습니다.
- 제품 유형별로는 2025년에 황반 건강을 지원하는 보충제 부문이 38%의 점유율을 차지하며 눈 건강 보충제 시장을 주도했습니다.
- 성분별로는 2025년 카로티노이드 부문이 36%의 점유율을 차지하며 눈 건강 보충제 시장을 주도했습니다.
- 제형별로는 2025년에 소프트젤 부문이 33%의 점유율을 차지하며 눈 건강 보충제 시장을 주도했습니다.
- 성분 조합별로는 2025년에 다성분 건강기능식품 부문이 눈 건강 기능식품 시장에서 57%의 점유율을 차지하며 시장을 주도했습니다.
- 유통 채널별로는 2025년 재택 케어 분야가 눈 건강 보충제 시장에서 52%의 점유율을 차지하며 시장을 주도했습니다.
- 북미는 2025년에 36%의 점유율을 차지하며 전 세계 눈 건강 보충제 시장의 매출을 주도했고, 지역별로는 전 세계에서 가장 높은 시장 점유율을 기록했습니다.
눈 건강 보충제는 루테인과 제아잔틴 등의 카로티노이드, 오메가-3 지방산, 비타민 A, 비타민 C, 비타민 E, 아연, 구리 등의 비타민·미네랄,빌베리나 사프란 추출물 등의 식물 유래 성분을 배합한 식품 및 영양보조식품으로, 황반 건강, 시기능, 그리고 눈의 편안함을 지원하도록 설계되었습니다. 노인성 황반변성, 백내장,건성안은 진행성 질환이며, 일단 진행되면 거의 되돌릴 수 없기 때문에 임상의와 소비자들은 국립안과연구소(NEI)가 지지하는 AREDS2 처방을 기반으로 한 영양 보충제를 임상 치료를 보완하는 예방 및 질환 진행 억제 수단으로 점점 더 많이 활용하고 있습니다. 본 시장은 제품 유형별로는 황반 건강, 시력 지원, 안구 건조증 지원, 기타 전문 보충제로 분류되며, 성분 유형별로는 카로티노이드, 오메가-3 지방산, 비타민·미네랄, 식물 유래 성분 등으로 분류되고, 제형별로는 정제, 액제, 캡슐, 소프트젤, 구미, 분말 등으로 분류됩니다. 배합별로는 단일 성분 건강기능식품, 다성분 건강기능식품, 항산화 물질 배합 제품, 기타로 분류됩니다. 또한 유통 채널별로는 병원, 전문 클리닉, 재택 간호 분야로 분류됩니다. 세계적인 고령화, 화면 시청 시간과 관련된 디지털 눈 피로 증가, 임상적으로 유효성이 확인된 AREDS2형 제제, 그리고 확대되는 예방적 자가 관리 문화에 힘입어 눈 건강 보충제는 소비자용 영양 보조 식품 및 안과 웰니스 분야에서 점점 더 주류 카테고리가 되어가고 있습니다.
눈 건강 보충제 시장의 주요 성장 동인
- 전 세계에서 시력 장애 및 노화에 따른 안과 질환의 유병률이 높아지고 있는 것이 수요를 견인하고 있으며, 세계보건기구(WHO)의 추정에 따르면 전 세계에서 22억 명 이상이 어떤 형태의 시력 장애를 앓고 있으며, 그 대부분은 조기 영양 개입을 통해 예방할 수 있습니다.
- 모든 연령대에서 화면을 보는 시간과 디지털 기기 사용이 급격히 증가함에 따라 디지털 눈의 피로를 완화하고 장기적인 황반 건강을 지원하는 루테인과 제아잔틴이 풍부하게 함유된 복합 제품에 대한 수요가 확대되고 있습니다.
- 중기 노인성 황반변성의 진행을 늦추는 AREDS2형 제제의 임상적으로 입증된 유효성은 안과 전문의들의 추천을 지속적으로 지원하고 있으며, 그 대표적인 예로 보쉬 롬(Bausch & Lomb)사가 2026년 5월 미국에서 출시할 예정인 ‘PreserVision AREDS3’를 들 수 있습니다. 이 제품은 AREDS2의 영양소와 독자적인 비타민 B 복합체를 결합한 것입니다.
- 구미, 액상 제제, 리포솜형 루테인 및 해조류 유래 DHA를 사용하여 생체 이용률을 높인 소프트젤 등 새로운 제형의 제품 혁신을 통해 기존의 정제 사용자를 넘어선 소비자층이 확대되고 있습니다.
- E-Commerce의 급속한 성장과 소비자 직접 판매(DTC)의 확대로 인해 예방적인 눈 헬스케어 솔루션을 찾는 젊은 층의 모바일 우선 소비자에 대한 접근성과 도달 범위가 넓어지고 있습니다.
- 안과 의사, 검안사 및 전문 안과 클리닉을 통한 눈 건강 보조제의 권장, 처방 및 판매가 증가함에 따라 임상적 신뢰도가 높아지고, 카테고리 전반에 대한 신뢰가 증진되고 있습니다.
- 전 세계 주요 소비자 건강 기업 및 전문 영양 보조제 제조사의 투자 증가, 신제품 출시, 제품 라인업 확충으로 인해 선진국 및 신흥 시장 전반에서 제품의 접근성이 높아지면서 카테고리의 성장이 가속화되고 있습니다.
눈 건강 보충제 시장 성장에 기여하는 요인
시장 촉진요인
노화에 따른 안과 질환의 전 세계 유병률 상승
눈 건강 보충제 시장의 가장 강력한 촉진요인은 노인성 황반변성, 백내장, 녹내장 등 노화에 따른 안과 질환의 전 세계적 부담 증가입니다. 세계보건기구(WHO)의 추정에 따르면 전 세계에서 22억 명 이상이 어떤 형태의 시력 장애를 겪고 있으며, 그 상당 부분이 예방 가능하거나 영양 섭취 개선을 통해 호전될 수 있는 질환과 관련되어 있습니다. 세계 인구의 고령화와 평균 수명의 연장에 따라 황반 및 망막 기능 저하가 진행될 위험이 있는 소비자층은 꾸준히 확대되고 있습니다. 루테인, 제아잔틴, 비타민 C, 비타민 E, 아연, 구리로 구성된 AREDS2 배합이 중등도 노인성 황반변성의 진행을 늦춘다는 것을 지원하는 임상적 근거는 안과 의사들의 권장 근거가 되고 있습니다. 진단율 향상과 예방적 영양에 대한 의식의 향상에 따라 임상적 근거에 기반한 황반 건강 유지 보충제에 대한 수요는 2034년까지 꾸준히 확대될 것으로 예상됩니다.
화면 시청 시간 증가와 디지털 눈의 피로
스마트폰, 노트북 및 기타 디지털 기기의 보급으로 인해 학생부터 직장인, 고령자에 이르기까지 모든 연령층에서 매일 화면에 노출되는 시간이 급격히 증가하고 있습니다. 화면 시청 시간의 장기화는 디지털 눈 피로, 안구 건조증 증상, 깜빡임 패턴의 이상과 밀접한 관련이 있으며, 디지털 웰니스와 눈의 편안함을 목적으로 판매되는 루테인, 제아잔틴, 오메가-3를 주성분으로 한 건강기능식품에 대한 소비자의 관심이 높아지고 있습니다. 특히 장시간 기기 사용 경향이 있는 밀레니얼 세대와 Z세대 소비자들은 보다 광범위한 자기 관리 및 웰니스 습관의 일환으로 눈 건강 보충제를 점점 더 많이 섭취하고 있습니다. 이러한 행동 변화로 인해 이 카테고리의 대상 소비자층은 기존에 AMD(노화성 황반변성) 예방 영양보조식품과 연관되어 온 고령층을 훨씬 넘어 확장되었으며, 예측 기간 중 수요 증가가 지속될 것으로 전망됩니다.
시장 제약 요인
강력한 성장 모멘텀에도 불구하고 눈 건강 보충제 시장은 중대한 제약에 직면해 있습니다. 영양 보조 식품 및 보충제의 효능 표기를 규제하는 체계는 지역마다 크게 달라 규정 준수상의 복잡성을 야기할 뿐만 아니라, AREDS2와 같이 임상적으로 입증된 처방을 제외하고는 제조사가 마케팅에서 주장할 수 있는 내용을 제한하고 있습니다. AREDS 이외의 많은 제제들은 견고하고 대규모의 임상적 근거가 부족하여, 의약품과 비교했을 때 의사의 추천이나 소비자의 신뢰를 저해할 가능성이 있습니다. 또한 눈 건강 보충제는 주로 본인 부담으로 구입하는 일반 의약품이며, 보험이나 환급 대상이 제한적이기 때문에 가격에 대한 민감성이 특히 신흥 시장에서 저소득층 소비자의 구매를 저해하는 요인이 되고 있습니다. 또한 이 카테고리는 임상적 근거보다 가격을 주요 경쟁 축으로 삼는 저가 제네릭 제품 및 자사 브랜드 제품과의 치열한 경쟁에 직면해 있으며, 고급 브랜드 제조사의 이익률에 압박을 가하고 있습니다. 규제가 느슨하고 시장이 세분화된 지역에서 유통되는 위조품이나 규격 미달 제품은 품질 및 안전성에 대한 우려를 야기하여, 카테고리 전체에 대한 소비자의 신뢰를 훼손할 우려가 있습니다. 더욱이 베타카로틴과 같은 고용량 보충제와 흡연자를 포함한 특정 환자 집단 간에 발생할 수 있는 상호작용에 대해서는 신중한 배합과 표시가 요구됩니다. 이러한 규제, 임상적 근거, 합리적인 가격, 품질 보증과 관련된 장벽들이 복합적으로 작용함에 따라 고령화, 디지털 눈 피로, 예방적 자가 관리와 같은 근본적인 성장 요인들이 여전히 견고함에도 불구하고 성장 속도는 둔화되고 있습니다.
자주 묻는 질문
목차
제1장 째 건강 보조제 시장 : 서론
제2장 째 건강 보조제 시장 : 개요
제3장 째 건강 보조제 시장 : 주요 요인 분석
제4장 AI, 지정학, 무역 및 경제의 동향
제5장 규제 분석
제6장 Porter's Five Forces 분석
제7장 째 건강 보조제 시장 : 평가
제8장 째 건강 보조제 시장 : 경쟁 구도
제9장 째 건강 보조제 시장 : 스타트업 자금조달 및 투자 동향
제10장 째 건강 보조제 시장 : 기업 개요 및 제품 개요
제11장 KOL의 견해
제12장 프로젝트·어프로치
제13장 DelveInsight 소개
제14장 면책사항 및 문의
KSA 26.09.10Eye Health Supplements Market Summary
Overview:
- The Eye Health Supplements market is estimated at USD 2.75 billion in 2025 and is projected to reach USD 5.40 billion by 2034. Growth is anchored in the rising global prevalence of age-related eye disorders, increasing screen-driven digital eye strain, and growing consumer preference for preventive, nutrition-based eye care.
- The global Eye Health Supplements market is growing at a CAGR of 7.8% during the forecast period from 2026 to 2034.
- By product type, the macular health supplements segment dominated the Eye Health Supplements market with a 38% share in 2025.
- By ingredient type, the carotenoids segment dominated the Eye Health Supplements market with a 36% share in 2025.
- By dosage form, the softgels segment dominated the Eye Health Supplements market with a 33% share in 2025.
- By formulation, the multi-ingredient supplements segment dominated the Eye Health Supplements market with a 57% share in 2025.
- By distribution channel, the home care settings segment dominated the Eye Health Supplements market with a 52% share in 2025.
- North America dominated the global Eye Health Supplements market revenue with a 36% share in 2025, representing the highest regional market share globally.
Eye health supplements are dietary and nutraceutical products formulated with carotenoids such as lutein and zeaxanthin, omega-3 fatty acids, vitamins and minerals including vitamin A, vitamin C, vitamin E, zinc, and copper, and botanical ingredients such as bilberry and saffron extract, designed to support macular health, visual function, and ocular comfort. Because age-related macular degeneration, cataract, and dry eye disease are progressive and largely irreversible once advanced, clinicians and consumers increasingly turn to nutritional supplementation, anchored by the National Eye Institute-backed AREDS2 formulation, as a preventive and disease-modifying complement to clinical care. The market is organized by product type across macular health, vision support, dry eye support, and other specialty supplements; by ingredient type across carotenoids, omega-3 fatty acids, vitamins and minerals, botanical ingredients, and others; by dosage form spanning tablets, liquids, capsules, softgels, gummies, powders, and others; by formulation spanning single-ingredient supplements, multi-ingredient supplements, combination antioxidant formulations, and others; and by distribution channel across hospitals, specialty clinics, and home care settings. Driven by an aging global population, rising screen-time-related digital eye strain, clinically validated AREDS2-style formulations, and an expanding preventive self-care culture, eye health supplements have become an increasingly mainstream category within consumer nutraceuticals and ophthalmic wellness.
Eye Health Supplements Market Key Growth Drivers
- The rising global prevalence of vision impairment and age-related eye disorders is driving demand, with the World Health Organization estimating that more than 2.2 billion people worldwide live with some form of vision impairment, a substantial share of which is preventable through early nutritional intervention.
- Rapidly increasing screen time and digital device usage across all age groups is expanding demand for lutein- and zeaxanthin-rich formulations that address digital eye strain and support long-term macular health.
- The clinically proven efficacy of AREDS2-type formulations in slowing the progression of intermediate age-related macular degeneration continues to reinforce ophthalmologist recommendations, exemplified by Bausch + Lomb's May 2026 U.S. launch of PreserVision AREDS3, which combines AREDS2 nutrients with a proprietary B-vitamin complex.
- Product innovation across new formats, including gummies, liquids, and enhanced-bioavailability softgels using liposomal lutein and algae-derived DHA, is broadening the consumer base beyond traditional tablet users.
- The rapid growth of e-commerce and direct-to-consumer End-Users is expanding access and reach to younger, mobile-first consumers seeking preventive eye care solutions.
- Growing recommendation and dispensing of eye health supplements by ophthalmologists, optometrists, and specialty eye-care clinics is reinforcing clinical credibility and driving category trust.
- Rising investment, new product launches, and portfolio expansion by both global consumer health majors and specialized nutraceutical players are broadening product availability and accelerating category growth across developed and emerging markets.
Key Companies in Eye Health Supplements Market
The competitive landscape is led by the following active manufacturers:
- Bausch + Lomb
- Alcon
- Sun Pharmaceutical Industries
- Micro Labs
- Ajanta Pharma
- Mankind Pharma
- Indoco Remedies
- MacuHealth
- ZeaVision
- Vitabiotics
Factors Contributing to the Growth of the Eye Health Supplements Market
Market Drivers
Rising Global Prevalence of Age-Related Eye Disorders
The most powerful driver of the Eye Health Supplements market is the rising global burden of age-related eye disorders, including age-related macular degeneration, cataract, and glaucoma. The World Health Organization estimates that more than 2.2 billion people worldwide live with some form of vision impairment, with a substantial proportion linked to preventable or nutritionally modifiable conditions. As the global population ages and life expectancy increases, the pool of consumers at risk of progressive macular and retinal decline expands steadily. Clinical evidence supporting the AREDS2 formulation, comprising lutein, zeaxanthin, vitamin C, vitamin E, zinc, and copper, in slowing the progression of intermediate AMD has become a cornerstone of ophthalmologist recommendations. As diagnosis rates improve and awareness of preventive nutrition grows, demand for clinically anchored macular health supplements is expected to expand steadily through 2034.
Increasing Screen Time and Digital Eye Strain
The proliferation of smartphones, laptops, and other digital devices has sharply increased daily screen exposure across all age groups, from students to working professionals to older adults. Extended screen time is closely associated with digital eye strain, dry eye symptoms, and disrupted blinking patterns, prompting rising consumer interest in lutein, zeaxanthin, and omega-3-based supplements marketed specifically for digital wellness and eye comfort. Millennials and Gen Z consumers, who are especially prone to prolonged device use, are increasingly adopting eye health supplements as part of broader self-care and wellness routines. This behavioral shift is broadening the addressable consumer base for the category well beyond the traditional older-adult demographic historically associated with AMD-focused nutrition, sustaining demand growth across the forecast period.
Market Restraints
Despite strong momentum, the Eye Health Supplements market faces material constraints. Regulatory frameworks governing nutraceutical and dietary supplement claims vary substantially across geographies, creating compliance complexity and limiting the marketing claims manufacturers can make outside clinically substantiated formulations such as AREDS2. Many non-AREDS formulations lack robust, large-scale clinical substantiation, which can limit physician endorsement and consumer confidence relative to pharmaceutical alternatives. Because eye health supplements are predominantly out-of-pocket, over-the-counter purchases with limited insurance or reimbursement coverage, price sensitivity constrains adoption among lower-income consumers, particularly in emerging markets. The category also faces intense competition from low-cost generic and private-label alternatives that compete primarily on price rather than clinical evidence, pressuring margins for premium branded players. Counterfeit and substandard products in fragmented, less-regulated markets raise quality and safety concerns that can undermine consumer trust in the broader category. Additionally, potential interactions between high-dose supplements, such as beta-carotene, and certain patient populations, including smokers, require careful formulation and labeling. Together, these regulatory, clinical-evidence, affordability, and quality-assurance barriers temper the pace of growth, even as the underlying drivers of aging demographics, digital eye strain, and preventive self-care remain firmly intact.
Eye Health Supplements Market Segment Analysis
The eye health supplements market by product type (macular health supplements, vision support supplements, dry eye support supplements, and others), ingredient type (carotenoids, omega-3 fatty acids, vitamins & minerals, botanical ingredients, and others), dosage forms (tablets, liquids, capsules, softgels, gummies, powders, and others), formulation (single-ingredient supplements, multi-ingredient supplements, combination antioxidant formulations, and others), end-users (hospitals, specialty clinics, and home care settings), and geography (North America, Europe, Asia-Pacific, and Rest of World).
By Product Type
Dominant Subsegment: Macular Health Supplements.
The macular health supplements segment accounted for 38% of the Eye Health Supplements market in 2025. Macular health supplements lead the market because age-related macular degeneration is the most clinically established and widely diagnosed condition addressed by nutritional supplementation, backed by the National Eye Institute's AREDS2 formulation and decades of longitudinal clinical evidence. The aging global population, combined with growing screening and early diagnosis of AMD, sustains great and dependable demand for lutein-, zeaxanthin-, and antioxidant-based macular formulations. Recent innovation, including Bausch + Lomb's May 2026 launch of PreserVision AREDS3, reinforces category leadership through expanded clinical positioning. While dry eye support supplements are the fastest-growing product type, propelled by rising digital eye strain, the depth of clinical evidence and scale of the AMD-affected population secure the macular health segment's leadership across the forecast period.
By Ingredient Type
Dominant Subsegment: Carotenoids.
The carotenoids segment accounted for 36% of the Eye Health Supplements market in 2025. Carotenoids, principally lutein and zeaxanthin, are the leading ingredient type because they form the clinically validated core of the AREDS2 formulation and are the most extensively studied nutrients for macular pigment density and AMD risk reduction. Their established safety profile, broad regulatory acceptance, and strong consumer recognition make carotenoid-based formulations the default choice for both clinicians and manufacturers. Omega-3 fatty acids are the fastest-growing ingredient type, supported by rising evidence linking DHA and EPA to dry eye relief and by innovation in algae-derived, plant-based sources offering higher bioavailability than conventional fish oil. Vitamins and minerals remain essential co-formulants within multi-nutrient blends, and botanical ingredients such as bilberry and saffron extract are gaining niche traction. Nonetheless, the breadth of clinical evidence and consumer familiarity keep carotenoids the dominant ingredient type across the forecast period.
Eye Health Supplements Market Region Analysis
Dominant Region: North America
North America accounted for 36% of the global Eye Health Supplements market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects high awareness of AMD and preventive eye nutrition, strong ophthalmologist and optometrist recommendation of AREDS2-based formulations, an established retail pharmacy and e-commerce infrastructure, and the presence of leading branded manufacturers such as Bausch + Lomb and Alcon. The United States leads the region on the strength of its aging population, high per-capita healthcare spending, and deep clinical evidence base supporting nutritional AMD management. Continued new product launches, including Bausch + Lomb's PreserVision AREDS3, alongside expanding direct-to-consumer distribution, reinforce the region's continued leadership across the forecast period.
Fastest Growing Region: Asia-Pacific
Asia-Pacific is the fastest-growing region in the Eye Health Supplements market. The region's elevated CAGR is driven by rising myopia and digital eye strain linked to intensive smartphone and screen use, expanding middle-class healthcare spending, and rapid growth of e-commerce channels across China, Japan, India, South Korea, and Australia. India's price-competitive manufacturing base and growing domestic nutraceutical industry, led by companies such as Sun Pharmaceutical Industries, Micro Labs, Ajanta Pharma, Mankind Pharma, and Indoco Remedies, is expanding access to affordable eye health formulations, while Japan continues to pioneer advanced bioavailable ingredient technologies. Rising awareness of preventive eye care and growing government health initiatives are accelerating adoption, positioning Asia-Pacific as the principal source of incremental growth over the forecast period.
Regional Commentary
North America
North America accounted for 36% of the global Eye Health Supplements market revenue in 2025. The United States dominates on the strength of its aging population, strong ophthalmology infrastructure, high consumer awareness of AMD nutrition, and the presence of leading branded manufacturers, while robust e-commerce penetration and continued product innovation reinforce its leadership.
Europe
Europe is a large and mature regional market, supported by strong consumer health awareness, established regulatory frameworks for nutraceutical claims, and a well-developed pharmacy and specialty retail infrastructure. Growing adoption of clinically substantiated formulations and expanding online retail are reinforcing the region's role in supplying eye health products across Germany, the United Kingdom, France, Italy, and Spain.
Asia-Pacific
Asia-Pacific is the fastest-growing region, propelled by rising digital eye strain, expanding healthcare investment, and growing nutraceutical manufacturing capacity across China, Japan, India, South Korea, and Australia. China's expanding wellness retail sector, Japan's advanced ingredient innovation, and India's cost-competitive domestic manufacturing base are accelerating regional category growth and e-commerce penetration.
Rest of World
The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding retail pharmacy and e-commerce infrastructure, rising awareness of preventive eye nutrition, and gradually improving regulatory clarity for nutraceutical products are broadening access, while international partnerships and distributor networks support the build-out of regional market presence.
Eye Health Supplements Market Competitive Landscape
The Eye Health Supplements market is classified as Fragmented. A group of established global consumer health and ophthalmic majors, including Bausch + Lomb, Alcon, and Vitabiotics, anchor the branded, clinically substantiated tier of the market, while regional pharmaceutical companies such as Sun Pharmaceutical Industries, Micro Labs, Ajanta Pharma, Mankind Pharma, and Indoco Remedies compete through affordable branded generics and expanding domestic distribution, and specialized nutraceutical players such as MacuHealth and ZeaVision compete through deep clinical evidence, physician channel relationships, and premium, condition-specific formulations.
The competitive landscape can be evaluated across the following dimensions:
- Market concentration: Fragmented, with global branded majors, regional pharmaceutical companies, and specialized clinical-nutrition players all competing for share.
- Leading players: Bausch + Lomb, Alcon, and Vitabiotics anchor the branded, clinically substantiated tier through decades of ophthalmic and consumer health expertise.
- Geographic reach: Leaders operate global distribution networks spanning retail pharmacy, specialty eye-care clinics, and e-commerce across developed and emerging markets.
- Product portfolio strength: Top players offer multi-format portfolios spanning softgels, gummies, liquids, and tablets across macular health, dry eye, and general vision support.
- Clinical evidence and ingredient sourcing: Ownership of proprietary, clinically studied formulations and secured sourcing of high-purity lutein, zeaxanthin, and algae-derived omega-3 ingredients is a decisive advantage.
- Strategic partnerships: Collaborations with ophthalmology associations, optometry networks, and research institutions extend clinical credibility and reach.
- M&A and portfolio activity: Ongoing brand and portfolio expansion, including new AREDS-based product launches and geographic distribution agreements, characterizes competitive activity.
- Manufacturing capabilities: GMP-certified nutraceutical manufacturing, encapsulation technology, and quality-control systems for lipid-soluble actives are key competitive moats.
- Innovation focus: Liposomal and enhanced-bioavailability delivery systems, algae-derived omega-3 sourcing, combination antioxidant formulations, and expansion into gummies and liquid formats.
Eye Health Supplements Market Recent Developmental Activities
In May 2026, Bausch + Lomb launched PreserVision AREDS3 eye vitamins in the United States, combining the clinically established AREDS2 nutrient formula with a proprietary B-vitamin complex intended to support macular health earlier in the progression of age-related macular degeneration. Strategic significance: Strengthens Bausch + Lomb's clinical leadership in AMD nutrition and extends its addressable patient population to earlier disease stages.
In 2026, Alcon continued to expand its consumer eye-care portfolio alongside its core surgical and vision-care businesses, broadening its presence in nutritional and ocular-comfort product categories. Strategic significance: Reinforces Alcon's positioning as a full-spectrum eye-care company spanning surgical, contact lens, and consumer nutrition offerings.
Eye Health Supplements Market Segmentation
Eye Health Supplements Market by Product Type
- Macular Health Supplements
- Vision Support Supplements
- Dry Eye Support Supplements
- Others
Eye Health Supplements Market by Ingredient Type
- Carotenoids
- Omega-3 Fatty Acids
- Vitamins & Minerals
- Botanical Ingredients
- Others
Eye Health Supplements Market by Dosage Forms
- Tablets
- Liquids
- Capsules
- Softgels
- Gummies
- Powders
- Others
Eye Health Supplements Market by Formulation
- Single-Ingredient Supplements
- Multi-Ingredient Supplements
- Combination Antioxidant Formulations
- Others
Eye Health Supplements Market by End-Users
- Hospitals
- Specialty Clinics
- Home Care Settings
- Others
Eye Health Supplements Market by Geography
- North America Eye Health Supplements Market
- United States Eye Health Supplements Market Size in USD million (2023-2034)
- Canada Eye Health Supplements Market Size in USD million (2023-2034)
- Mexico Eye Health Supplements Market Size in USD million (2023-2034)
- Europe Eye Health Supplements Market
- Germany Eye Health Supplements Market Size in USD million (2023-2034)
- United Kingdom Eye Health Supplements Market Size in USD million (2023-2034)
- France Eye Health Supplements Market Size in USD million (2023-2034)
- Italy Eye Health Supplements Market Size in USD million (2023-2034)
- Spain Eye Health Supplements Market Size in USD million (2023-2034)
- Rest of Europe Eye Health Supplements Market Size in USD million (2023-2034)
- Asia-Pacific Eye Health Supplements Market
- China Eye Health Supplements Market Size in USD million (2023-2034)
- Japan Eye Health Supplements Market Size in USD million (2023-2034)
- India Eye Health Supplements Market Size in USD million (2023-2034)
- Australia Eye Health Supplements Market Size in USD million (2023-2034)
- South Korea Eye Health Supplements Market Size in USD million (2023-2034)
- Rest of Asia-Pacific Eye Health Supplements Market Size in USD million (2023-2034)
- Rest of the World (RoW) Eye Health Supplements Market
- Middle East Eye Health Supplements Market Size in USD million (2023-2034)
- Africa Eye Health Supplements Market Size in USD million (2023-2034)
- South America Eye Health Supplements Market Size in USD million (2023-2034)
Key Takeaways from the Eye Health Supplements Market Report Study
- Market size analysis for the current Eye Health Supplements market size (2025), and market forecast for 9 years (2026 to 2034).
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
- Key companies dominating the global Eye Health Supplements market.
- Various opportunities available for competitors in the Eye Health Supplements market space.
- What are the top-performing segments in 2025? How will these segments perform in 2034?
- Which are the top-performing regions and countries in the current Eye Health Supplements market scenario?
- Which are the regions and countries where companies should concentrate their opportunities for Eye Health Supplements market growth in the future?
Target audience who can benefit from this Eye Health Supplements market report study
- Eye Health Supplements product providers
- Research organizations and consulting companies
- Eye Health Supplements -related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and traders dealing in Eye Health Supplements
- Various end-users who want to know more about the Eye Health Supplements market and the latest technological developments in the Eye Health Supplements market.
Frequently Asked Questions:
Q1. What is the growth rate of the Eye Health Supplements market?
The Eye Health Supplements market is projected to expand at a CAGR of 7.8% during the forecast period from 2026-2034.
Q2. What is the market size of the Eye Health Supplements market?
The Eye Health Supplements market is estimated at USD 2.75 billion in 2025 and is projected to reach USD 5.40 billion by 2034.
Q3. Which region dominates the Eye Health Supplements market?
North America dominated the Eye Health Supplements market with a 36% share of global revenue in 2025, supported by high awareness of AMD nutrition, strong ophthalmologist and optometrist recommendation of clinically validated formulations, an established retail and e-commerce infrastructure, and the presence of leading branded manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.
Q4. What are the key drivers of the Eye Health Supplements market?
The principal drivers are the rising global prevalence of age-related eye disorders, with the World Health Organization estimating more than 2.2 billion people worldwide affected by vision impairment; increasing screen time and digital eye strain across all age groups; the clinically proven efficacy of AREDS2-type formulations; expanding product innovation across new formats and bioavailable ingredients; and the rapid growth of e-commerce and direct-to-consumer End-Users.
Q5. Who are the major players in the Eye Health Supplements market?
The major players include Bausch + Lomb, Alcon, Sun Pharmaceutical Industries, Micro Labs, Ajanta Pharma, Mankind Pharma, Indoco Remedies, MacuHealth, ZeaVision, and Vitabiotics, among other active manufacturers profiled in the Competitive Landscape section. Bausch + Lomb, Alcon, and Vitabiotics lead through global branded reach and clinically substantiated formulations.
Table of Contents
1. Eye Health Supplements Market Report Introduction
- 1.1 Scope of the Study
- 1.2 Market Segmentation
- 1.3 Market Assumptions
2. Eye Health Supplements Market Executive Summary
- 2.1 Market at a Glance
3. Eye Health Supplements Market Key Factors Analysis
- 3.1 Eye Health Supplements Market Drivers
- 3.1.1 Rising Prevalence of Age-Related Eye Disorders
- 3.1.2 Increasing Screen Time and Digital Eye Strain
- 3.1.3 Clinically Validated AREDS2-Style Formulations
- 3.1.4 Product Innovation and E-Commerce Expansion
- 3.2 Eye Health Supplements Market Restraints and Challenges
- 3.2.1 Regulatory Variability and Limited Clinical Substantiation
- 3.2.2 Price Sensitivity and Limited Reimbursement
- 3.2.3 Competition from Generic and Private-Label Products
- 3.3 Eye Health Supplements Market Opportunities
- 3.3.1 Enhanced-Bioavailability Delivery Systems
- 3.3.2 Emerging-Market and Digital Channel Expansion
4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
5. Regulatory Analysis
- 5.1 United States
- 5.2 Europe
- 5.3 Japan
- 5.4 China
6. Eye Health Supplements Market Porter's Five Forces Analysis
- 6.1 Bargaining Power of Suppliers
- 6.2 Bargaining Power of Buyers
- 6.3 Threat of New Entrants
- 6.4 Threat of Substitutes
- 6.5 Competitive Rivalry
7. Eye Health Supplements Market Assessment
- 7.1 By Product Type
- 7.1.1 Macular Health Supplements
- 7.1.2 Vision Support Supplements
- 7.1.3 Dry Eye Support Supplements
- 7.1.4 Others
- 7.2 By Ingredient Type
- 7.2.1 Carotenoids
- 7.2.2 Omega-3 Fatty Acids
- 7.2.3 Vitamins & Minerals
- 7.2.4 Botanical Ingredients
- 7.2.5 Others
- 7.3 By Dosage Forms
- 7.3.1 Tablets
- 7.3.2 Liquids
- 7.3.3 Capsules
- 7.3.4 Softgels
- 7.3.5 Gummies
- 7.3.6 Powders
- 7.3.7 Others
- 7.4 By Formulation
- 7.4.1 Single-Ingredient Supplements
- 7.4.2 Multi-Ingredient Supplements
- 7.4.3 Combination Antioxidant Formulations
- 7.4.4 Others
- 7.5 By End-Users
- 7.5.1 Hospitals
- 7.5.2 Specialty Clinics
- 7.5.3 Home Care Settings
- 7.5.4 Others
- 7.6 By Geography
- 7.6.1 North America
- 7.6.1.1 United States Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.1.2 Canada Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.1.3 Mexico Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.2 Europe
- 7.6.2.1 Germany Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.2.2 United Kingdom Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.2.3 France Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.2.4 Italy Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.2.5 Spain Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.2.6 Rest of Europe Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.3 Asia-Pacific
- 7.6.3.1 China Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.3.2 Japan Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.3.3 India Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.3.4 Australia Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.3.5 South Korea Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.3.6 Rest of Asia-Pacific Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.4 Rest of World
- 7.6.4.1 Middle East Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.4.2 Africa Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.4.3 South America Eye Health Supplements Market Size in USD million (2023-2034)
- 7.6.1 North America
8. Eye Health Supplements Market Competitive Landscape
- 8.1 Market Concentration and Structure
- 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)
9. Eye Health Supplements Market Startup Funding and Investment Trends
10. Eye Health Supplements Market Company and Product Profiles
- 10.1 Bausch + Lomb
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Service Portfolio
- 10.1.5 Strategic Initiatives / Entropy
- 10.2 Alcon
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Portfolio
- 10.2.5 Strategic Initiatives / Entropy
- 10.3 Sun Pharmaceutical Industries
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Portfolio
- 10.3.5 Strategic Initiatives / Entropy
- 10.4 Micro Labs
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Portfolio
- 10.4.5 Strategic Initiatives / Entropy
- 10.5 Ajanta Pharma
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Portfolio
- 10.5.5 Strategic Initiatives / Entropy
- 10.6 Mankind Pharma
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Portfolio
- 10.6.5 Strategic Initiatives / Entropy
- 10.7 Indoco Remedies
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Portfolio
- 10.7.5 Strategic Initiatives / Entropy
- 10.8 MacuHealth
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Portfolio
- 10.8.5 Strategic Initiatives / Entropy
- 10.9 ZeaVision
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Portfolio
- 10.9.5 Strategic Initiatives / Entropy
10. Vitabiotics
- 10.10.1 Company Overview
- 10.10.2 Company Snapshot
- 10.10.3 Financial Overview
- 10.10.4 Product Portfolio
- 10.10.5 Strategic Initiatives / Entropy
For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.
